Your browser doesn't support javascript.
loading
Gastrointestinal Dysmotility Is a Significant Feature in 2 Siblings With a Novel Inositol 1,4,5-Triphosphate Receptor 1 (ITPR1) Missense Variant.
Butler Tjaden, Naomi E; Chiou, Eric H; Pillai, Nishitha R; Schady, Deborah A; Chumpitazi, Bruno P.
Afiliação
  • Butler Tjaden NE; Pediatrician-Scientist Training and Development Program, Baylor College of Medicine, Houston, TX.
  • Chiou EH; Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Pillai NR; Division of GI, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Schady DA; Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Chumpitazi BP; Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, TX.
ACG Case Rep J ; 8(10): e00676, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34722792
ABSTRACT
We present 2 siblings with a novel type 1 inositol 1,4,5-triphosphate receptor (ITPR1) missense variant who exhibit gastrointestinal dysmotility (chronic constipation and gastroparesis). ITPR1 is expressed in the cerebellum and interstitial cells of Cajal. Periodic release of calcium by ITPR1 initiates pacemaker currents, resulting in smooth muscle contraction. ITPR1 mutations are known to be associated with neurologic syndromes, and these variants have not previously been associated with significant gastrointestinal manifestations in humans. Using whole-genome sequencing, in silico prediction software, biopsy samples, and manometry, the identified novel ITPR1 variant is likely pathogenic and may have neurogastroenterology implications.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article